カテゴリー： Market Monitor Global, 世界, 医療/バイオ

LSD1抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル

◆英語タイトル：LSD1 Antibody Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12390）◆商品コード：MMG23DC12390
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のLSD1抗体市場規模と予測を収録しています。・世界のLSD1抗体市場：売上、2018年-2023年、2024年-2029年
・世界のLSD1抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のLSD1抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

LSD1抗体のグローバル主要企業は、Bioss、 Thermo Fisher Scientific、 Proteintech Group、 BPS Bioscience、 Enzo Life Sciences、 RayBiotech、 Abcam、 GeneTex、 ProSci、 Cell Signaling Technology、 HUABIO、 Bethyl Laboratories、 Abeomics、 Novus Biologicals、 NSJ Bioreagents、 Agrisera、 Biobyt、 Jingjie PTM BioLabなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、LSD1抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のLSD1抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界のLSD1抗体市場：タイプ別市場シェア、2022年
・モノクローナル、ポリクローナル

世界のLSD1抗体市場：用途別、2018年-2023年、2024年-2029年
世界のLSD1抗体市場：用途別市場シェア、2022年
・免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他

世界のLSD1抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界のLSD1抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるLSD1抗体のグローバル売上、2018年-2023年
・主要企業におけるLSD1抗体のグローバル売上シェア、2022年
・主要企業におけるLSD1抗体のグローバル販売量、2018年-2023年
・主要企業におけるLSD1抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bioss、 Thermo Fisher Scientific、 Proteintech Group、 BPS Bioscience、 Enzo Life Sciences、 RayBiotech、 Abcam、 GeneTex、 ProSci、 Cell Signaling Technology、 HUABIO、 Bethyl Laboratories、 Abeomics、 Novus Biologicals、 NSJ Bioreagents、 Agrisera、 Biobyt、 Jingjie PTM BioLab

*************************************************************

・調査・分析レポートの概要
LSD1抗体市場の定義
市場セグメント
世界のLSD1抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のLSD1抗体市場規模
世界のLSD1抗体市場規模：2022年 VS 2029年
世界のLSD1抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのLSD1抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のLSD1抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：モノクローナル、ポリクローナル
LSD1抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他
LSD1抗体の用途別グローバル売上・予測

・地域別市場分析
地域別LSD1抗体市場規模 2022年と2029年
地域別LSD1抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Bioss、 Thermo Fisher Scientific、 Proteintech Group、 BPS Bioscience、 Enzo Life Sciences、 RayBiotech、 Abcam、 GeneTex、 ProSci、 Cell Signaling Technology、 HUABIO、 Bethyl Laboratories、 Abeomics、 Novus Biologicals、 NSJ Bioreagents、 Agrisera、 Biobyt、 Jingjie PTM BioLab
...

This research report provides a comprehensive analysis of the LSD1 Antibody market, focusing on the current trends, market dynamics, and future prospects. The report explores the global LSD1 Antibody market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of LSD1 Antibody, challenges faced by the industry, and potential opportunities for market players.
The global LSD1 Antibody market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The LSD1 Antibody market presents opportunities for various stakeholders, including Immunochemistry (IHC), Immunofluorescence (IF). Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in LSD1 Antibody market. Additionally, the growing consumer demand present avenues for market expansion.
The global LSD1 Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the LSD1 Antibody market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the LSD1 Antibody market.
Market Overview: The report provides a comprehensive overview of the LSD1 Antibody market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal, Polyclonal), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the LSD1 Antibody market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the LSD1 Antibody market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the LSD1 Antibody market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the LSD1 Antibody market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the LSD1 Antibody market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the LSD1 Antibody market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for LSD1 Antibody, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the LSD1 Antibody market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
LSD1 Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal
Polyclonal
Market segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Global LSD1 Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bioss
Thermo Fisher Scientific
Proteintech Group
BPS Bioscience
Enzo Life Sciences
RayBiotech
Abcam
GeneTex
ProSci
Cell Signaling Technology
HUABIO
Bethyl Laboratories
Abeomics
Novus Biologicals
NSJ Bioreagents
Agrisera
Biobyt
Jingjie PTM BioLab
Outline of Major Chapters:
Chapter 1: Introduces the definition of LSD1 Antibody, market overview.
Chapter 2: Global LSD1 Antibody market size in revenue.
Chapter 3: Detailed analysis of LSD1 Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of LSD1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 LSD1 Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global LSD1 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global LSD1 Antibody Overall Market Size
2.1 Global LSD1 Antibody Market Size: 2022 VS 2029
2.2 Global LSD1 Antibody Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top LSD1 Antibody Players in Global Market
3.2 Top Global LSD1 Antibody Companies Ranked by Revenue
3.3 Global LSD1 Antibody Revenue by Companies
3.4 Top 3 and Top 5 LSD1 Antibody Companies in Global Market, by Revenue in 2022
3.5 Global Companies LSD1 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 LSD1 Antibody Players in Global Market
3.6.1 List of Global Tier 1 LSD1 Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 LSD1 Antibody Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global LSD1 Antibody Market Size Markets, 2022 & 2029
4.1.2 Monoclonal
4.1.3 Polyclonal
4.2 By Type – Global LSD1 Antibody Revenue & Forecasts
4.2.1 By Type – Global LSD1 Antibody Revenue, 2018-2023
4.2.2 By Type – Global LSD1 Antibody Revenue, 2024-2029
4.2.3 By Type – Global LSD1 Antibody Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global LSD1 Antibody Market Size, 2022 & 2029
5.1.2 Immunochemistry (IHC)
5.1.3 Immunofluorescence (IF)
5.1.4 Immunoprecipitation (IP)
5.1.5 Western Blot (WB)
5.1.6 ELISA
5.1.7 Others
5.2 By Application – Global LSD1 Antibody Revenue & Forecasts
5.2.1 By Application – Global LSD1 Antibody Revenue, 2018-2023
5.2.2 By Application – Global LSD1 Antibody Revenue, 2024-2029
5.2.3 By Application – Global LSD1 Antibody Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global LSD1 Antibody Market Size, 2022 & 2029
6.2 By Region – Global LSD1 Antibody Revenue & Forecasts
6.2.1 By Region – Global LSD1 Antibody Revenue, 2018-2023
6.2.2 By Region – Global LSD1 Antibody Revenue, 2024-2029
6.2.3 By Region – Global LSD1 Antibody Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America LSD1 Antibody Revenue, 2018-2029
6.3.2 US LSD1 Antibody Market Size, 2018-2029
6.3.3 Canada LSD1 Antibody Market Size, 2018-2029
6.3.4 Mexico LSD1 Antibody Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe LSD1 Antibody Revenue, 2018-2029
6.4.2 Germany LSD1 Antibody Market Size, 2018-2029
6.4.3 France LSD1 Antibody Market Size, 2018-2029
6.4.4 U.K. LSD1 Antibody Market Size, 2018-2029
6.4.5 Italy LSD1 Antibody Market Size, 2018-2029
6.4.6 Russia LSD1 Antibody Market Size, 2018-2029
6.4.7 Nordic Countries LSD1 Antibody Market Size, 2018-2029
6.4.8 Benelux LSD1 Antibody Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia LSD1 Antibody Revenue, 2018-2029
6.5.2 China LSD1 Antibody Market Size, 2018-2029
6.5.3 Japan LSD1 Antibody Market Size, 2018-2029
6.5.4 South Korea LSD1 Antibody Market Size, 2018-2029
6.5.5 Southeast Asia LSD1 Antibody Market Size, 2018-2029
6.5.6 India LSD1 Antibody Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America LSD1 Antibody Revenue, 2018-2029
6.6.2 Brazil LSD1 Antibody Market Size, 2018-2029
6.6.3 Argentina LSD1 Antibody Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa LSD1 Antibody Revenue, 2018-2029
6.7.2 Turkey LSD1 Antibody Market Size, 2018-2029
6.7.3 Israel LSD1 Antibody Market Size, 2018-2029
6.7.4 Saudi Arabia LSD1 Antibody Market Size, 2018-2029
6.7.5 UAE LSD1 Antibody Market Size, 2018-2029
7 LSD1 Antibody Companies Profiles
7.1 Bioss
7.1.1 Bioss Company Summary
7.1.2 Bioss Business Overview
7.1.3 Bioss LSD1 Antibody Major Product Offerings
7.1.4 Bioss LSD1 Antibody Revenue in Global Market (2018-2023)
7.1.5 Bioss Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific LSD1 Antibody Major Product Offerings
7.2.4 Thermo Fisher Scientific LSD1 Antibody Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Proteintech Group
7.3.1 Proteintech Group Company Summary
7.3.2 Proteintech Group Business Overview
7.3.3 Proteintech Group LSD1 Antibody Major Product Offerings
7.3.4 Proteintech Group LSD1 Antibody Revenue in Global Market (2018-2023)
7.3.5 Proteintech Group Key News & Latest Developments
7.4 BPS Bioscience
7.4.1 BPS Bioscience Company Summary
7.4.2 BPS Bioscience Business Overview
7.4.3 BPS Bioscience LSD1 Antibody Major Product Offerings
7.4.4 BPS Bioscience LSD1 Antibody Revenue in Global Market (2018-2023)
7.4.5 BPS Bioscience Key News & Latest Developments
7.5 Enzo Life Sciences
7.5.1 Enzo Life Sciences Company Summary
7.5.2 Enzo Life Sciences Business Overview
7.5.3 Enzo Life Sciences LSD1 Antibody Major Product Offerings
7.5.4 Enzo Life Sciences LSD1 Antibody Revenue in Global Market (2018-2023)
7.5.5 Enzo Life Sciences Key News & Latest Developments
7.6 RayBiotech
7.6.1 RayBiotech Company Summary
7.6.2 RayBiotech Business Overview
7.6.3 RayBiotech LSD1 Antibody Major Product Offerings
7.6.4 RayBiotech LSD1 Antibody Revenue in Global Market (2018-2023)
7.6.5 RayBiotech Key News & Latest Developments
7.7 Abcam
7.7.1 Abcam Company Summary
7.7.2 Abcam Business Overview
7.7.3 Abcam LSD1 Antibody Major Product Offerings
7.7.4 Abcam LSD1 Antibody Revenue in Global Market (2018-2023)
7.7.5 Abcam Key News & Latest Developments
7.8 GeneTex
7.8.1 GeneTex Company Summary
7.8.2 GeneTex Business Overview
7.8.3 GeneTex LSD1 Antibody Major Product Offerings
7.8.4 GeneTex LSD1 Antibody Revenue in Global Market (2018-2023)
7.8.5 GeneTex Key News & Latest Developments
7.9 ProSci
7.9.1 ProSci Company Summary
7.9.2 ProSci Business Overview
7.9.3 ProSci LSD1 Antibody Major Product Offerings
7.9.4 ProSci LSD1 Antibody Revenue in Global Market (2018-2023)
7.9.5 ProSci Key News & Latest Developments
7.10 Cell Signaling Technology
7.10.1 Cell Signaling Technology Company Summary
7.10.2 Cell Signaling Technology Business Overview
7.10.3 Cell Signaling Technology LSD1 Antibody Major Product Offerings
7.10.4 Cell Signaling Technology LSD1 Antibody Revenue in Global Market (2018-2023)
7.10.5 Cell Signaling Technology Key News & Latest Developments
7.11 HUABIO
7.11.1 HUABIO Company Summary
7.11.2 HUABIO Business Overview
7.11.3 HUABIO LSD1 Antibody Major Product Offerings
7.11.4 HUABIO LSD1 Antibody Revenue in Global Market (2018-2023)
7.11.5 HUABIO Key News & Latest Developments
7.12 Bethyl Laboratories
7.12.1 Bethyl Laboratories Company Summary
7.12.2 Bethyl Laboratories Business Overview
7.12.3 Bethyl Laboratories LSD1 Antibody Major Product Offerings
7.12.4 Bethyl Laboratories LSD1 Antibody Revenue in Global Market (2018-2023)
7.12.5 Bethyl Laboratories Key News & Latest Developments
7.13 Abeomics
7.13.1 Abeomics Company Summary
7.13.2 Abeomics Business Overview
7.13.3 Abeomics LSD1 Antibody Major Product Offerings
7.13.4 Abeomics LSD1 Antibody Revenue in Global Market (2018-2023)
7.13.5 Abeomics Key News & Latest Developments
7.14 Novus Biologicals
7.14.1 Novus Biologicals Company Summary
7.14.2 Novus Biologicals Business Overview
7.14.3 Novus Biologicals LSD1 Antibody Major Product Offerings
7.14.4 Novus Biologicals LSD1 Antibody Revenue in Global Market (2018-2023)
7.14.5 Novus Biologicals Key News & Latest Developments
7.15 NSJ Bioreagents
7.15.1 NSJ Bioreagents Company Summary
7.15.2 NSJ Bioreagents Business Overview
7.15.3 NSJ Bioreagents LSD1 Antibody Major Product Offerings
7.15.4 NSJ Bioreagents LSD1 Antibody Revenue in Global Market (2018-2023)
7.15.5 NSJ Bioreagents Key News & Latest Developments
7.16 Agrisera
7.16.1 Agrisera Company Summary
7.16.2 Agrisera Business Overview
7.16.3 Agrisera LSD1 Antibody Major Product Offerings
7.16.4 Agrisera LSD1 Antibody Revenue in Global Market (2018-2023)
7.16.5 Agrisera Key News & Latest Developments
7.17 Biobyt
7.17.1 Biobyt Company Summary
7.17.2 Biobyt Business Overview
7.17.3 Biobyt LSD1 Antibody Major Product Offerings
7.17.4 Biobyt LSD1 Antibody Revenue in Global Market (2018-2023)
7.17.5 Biobyt Key News & Latest Developments
7.18 Jingjie PTM BioLab
7.18.1 Jingjie PTM BioLab Company Summary
7.18.2 Jingjie PTM BioLab Business Overview
7.18.3 Jingjie PTM BioLab LSD1 Antibody Major Product Offerings
7.18.4 Jingjie PTM BioLab LSD1 Antibody Revenue in Global Market (2018-2023)
7.18.5 Jingjie PTM BioLab Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ LSD1抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル(LSD1 Antibody Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • STT3A抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • ENO3抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • 抗R1抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • CD115抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • CD55抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル